Search Results - "Santoni-Rugiu, Eric"

Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts.

Authors: Buhl, Ida Kappel Santoni-Rugiu, Eric Ravn, Jesper et al.

Source: PLoS ONE. 3/22/2018, Vol. 13 Issue 3, p1-18. 18p.

This result is not displayed to guests.
Login for full access.

MicroRNAs as potential biomarkers in malignant pleural mesothelioma.

Authors: Santoni-Rugiu, Eric Andersen, Morten Grauslund, Morten

Source: Current Biomarker Findings. Jan2016, Vol. 6, p1-21. 21p.

Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer.

Authors: Jakobsen, Jan N Santoni‐Rugiu, Eric Sørensen, Jens B

Source: Histopathology. Feb2014, Vol. 64 Issue 3, p412-420. 9p.

Lipcalin 2 is protective against E. coli pneumonia.

Authors: Hong Wu Santoni-Rugiu, Eric Ralfkiaer, Elisabeth et al.

Source: Respiratory Research. 2010, Vol. 11, p96-103. 8p.

Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion.

Authors: Santoni-Rugiu, Eric Jelnes, Peter Thorgeirsson, Snorri S. et al.

Source: APMIS. Nov/Dec2005, Vol. 113 Issue 11/12, p876-902. 27p. 1 Color Photograph, 1 Diagram, 2 Charts.

Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS.

Authors: Agger, Karl Santoni-Rugiu, Eric Holmberg, Christian et al.

Source: Oncogene. 1/27/2005, Vol. 24 Issue 5, p780-789. 10p.

E2F activity is essential for survival of Myc-overexpressing human cancer cells.

Authors: Santoni-Rugiu, Eric Duro, Dominique Farkas, Thomas et al.

Source: Oncogene. 9/19/2002, Vol. 21 Issue 42, p6498. 12p. 2 Black and White Photographs, 3 Charts, 9 Graphs.

Ossifying thymoma associated with refractory myasthenia gravis.

Authors: SANTONI-RUGIU, ERIC RAVN, JESPER SEHESTED, MAXWELL et al.

Source: APMIS. Apr2010, Vol. 118 Issue 4, p334-336. 3p. 1 Color Photograph.

Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma.

Authors: Santoni-Rugiu, Eric Lü, Maya Jeje Schuang Jakobsen, Jan Nyrop et al.

Source: International Journal of Molecular Sciences. Dec2021, Vol. 22 Issue 23, p12868. 1p.

This result is not displayed to guests.
Login for full access.

Improvement of Diagnostics in NSCLC Patients with MET Exon 14 Mutations Using Complementary DNA/RNA-NGS and Identification of Two Novel Exonic Splicing Mutations.

Authors: Urbanska, Edyta Maria Doktor, Thomas Koed Melchior, Linea Cecilie et al.

Source: International Journal of Molecular Sciences. Jan2026, Vol. 27 Issue 1, p106. 15p.

Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.

Authors: Santoni-Rugiu, Eric Grauslund, Morten Melchior, Linea C. et al.

Source: Lung Cancer (01695002). Nov2017, Vol. 113, p14-17. 4p.

Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors.

Authors: Egebjerg, Kristian Spanggaard, Iben Ahlborn, Lise Barlebo et al.

Source: BMC Cancer. 8/6/2025, Vol. 25 Issue 1, p1-11. 11p.

Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance.

Authors: Santoni-Rugiu, Eric Melchior, Linea C. Urbanska, Edyta M. et al.

Source: Cancers. Jul2019, Vol. 11 Issue 7, p923-923. 1p.

Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer.

Authors: Jakobsen, Jan Santoni-Rugiu, Eric Sørensen, Jens

Source: Journal of Cancer Research & Clinical Oncology. Apr2014, Vol. 140 Issue 4, p645-652. 8p.

Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients.

Authors: Jakobsen, Jan Santoni-Rugiu, Eric Sørensen, Jens

Source: Cancer Chemotherapy & Pharmacology. Jan2014, Vol. 73 Issue 1, p43-51. 9p.

Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer.

Authors: Jakobsen, Jan Santoni-Rugiu, Eric Sørensen, Jens

Source: Cancer Chemotherapy & Pharmacology. Jan2014, Vol. 73 Issue 1, p131-137. 7p.

This result is not displayed to guests.
Login for full access.

Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer.

Authors: Jakobsen, Jan Nyrop Santoni-Rugiu, Eric Ravn, Jesper et al.

Source: European Journal of Cancer. Jul2013, Vol. 49 Issue 11, p2494-2503. 10p.